EU to order more Pfizer vaccine after declining earlier offer - (London South East via NewsPoints Desk)

  • The EU will take up its option to buy up to 100 million more doses of Pfizer and BioNTech's COVID-19 vaccine after turning down an opportunity in July for a much bigger deal, as reported in London South East.

  • The news source said the plan comes after some of the vaccine candidates ordered by the EU faced unexpected delays in clinical trials, forcing the bloc and other wealthy nations to rely for now on doses from fewer manufacturers than initially planned.

  • Under the EU contract, the two firms have committed to rapidly deliver 200 million doses after regulatory approval for €15.5 per dose, EU officials said in November. The extra 100 million doses would be supplied at the same price, but with the timetable to be negotiated, EU officials said.

  • According to internal documents, at a meeting with EU diplomats in July, a Commission official said the EU had declined an offer of 500 million doses from Pfizer and BioNTech because it was too expensive.

  • Pfizer's vaccines for the EU are produced at a plant in Belgium, but the factory is currently also supplying the US, the UK and Canada.

  • "We have millions of doses ready… for distribution, depending on regulatory approval," a spokesman for the plant said, when asked whether shipments to countries outside the EU could temporarily reduce supplies to the bloc.

To read more NewsPoints articles, click here.